Key Insights

Highlights

Treatment Research

3 treatments under study, led by Standard Treatment

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Withdrawn1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT04951934Not ApplicableWithdrawn

Prospective Randomized International Study on the Reactivation of Burn Injuries

NCT04185636UnknownPrimary

Presence of Fluorescence Signature to Predict Graft Failure Using MolecuLight i:X

Showing all 2 trials

Research Network

Common Treatments

  • Standard Treatment1
  • Emoled1
  • Moleculight Ix Imaging1

Active Sponsors

  • Emoled1
  • MolecuLight Inc.1

Top Investigators

Related Conditions

  • Burns1

Activity Timeline